Infusion Therapy Market (Product: Infusion Pumps, Infusion Set, and Accessories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Infusion Therapy Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Porter's Five Force Analysis

5. Key Insights

• 5.1. Key Industry Developments
• 5.2. Disease Prevalence & Incidence Rate globally with key countries
• 5.3. Technological Advancements
• 5.4. Regulatory Scenario by Region/globally
• 5.5. Covid-19 Pandemic impact on the industry

6. Global Infusion Therapy Market Analysis and Forecast, by Product

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast, by Product, 2017-2031
  • 6.3.1. Infusion Pumps
    • 6.3.1.1. Ambulatory Infusion Pumps
    • 6.3.1.2. Stationary Infusion Pumps
    • 6.3.1.3. Syringe Infusion Pumps
    • 6.3.1.4. Disposable Pumps
    • 6.3.1.5. Large Volume Pumps
    • 6.3.1.6. Elastomeric Pumps
  • 6.3.2. Infusion Set
  • 6.3.3. Accessories
• 6.4. Market Attractiveness Analysis, by Product

7. Global Infusion Therapy Market Analysis and Forecast, by Indication

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast, by Indication, 2017-2031
  • 7.3.1. Cancer
  • 7.3.2. Gastrointestinal Diseases / Disorders
  • 7.3.3. Congestive Heart Failure
  • 7.3.4. Rheumatoid Arthritis
  • 7.3.5. Hemophilia
  • 7.3.6. Immune Deficiencies
  • 7.3.7. Others
• 7.4. Market Attractiveness Analysis, by Indication

8. Global Infusion Therapy Market Analysis and Forecast, by Therapy Type

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast, by Therapy Type, 2017-2031
  • 8.3.1. Antibiotic/Antiviral
  • 8.3.2. Anti-coagulation
  • 8.3.3. Anti-emetics
  • 8.3.4. Blood Component Stimulating Factor
  • 8.3.5. Chemotherapy
  • 8.3.6. Nutrition
  • 8.3.7. Hydration
  • 8.3.8. Pain Management
• 8.4. Market Attractiveness Analysis, by Therapy Type

9. Global Infusion Therapy Market Analysis and Forecast, by End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast, by End-user, 2017-2031
  • 9.3.1. Hospitals
  • 9.3.2. Ambulatory Surgical Centers
  • 9.3.3. Clinics
  • 9.3.4. Homecare Settings
• 9.4. Market Attractiveness Analysis, by End-user

10. Global Infusion Therapy Market Analysis and Forecast, by Region

• 10.1. Key Findings
• 10.2. Market Value Forecast, by Region
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness Analysis, by Region

11. North America Infusion Therapy Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product, 2017-2031
  • 11.2.1. Infusion Pumps
    • 11.2.1.1. Ambulatory Infusion Pumps
    • 11.2.1.2. Stationary Infusion Pumps
    • 11.2.1.3. Syringe Infusion Pumps
    • 11.2.1.4. Disposable Pumps
    • 11.2.1.5. Large Volume Pumps
    • 11.2.1.6. Elastomeric Pumps
  • 11.2.2. Infusion Set
  • 11.2.3. Accessories
• 11.3. Market Value Forecast, by Indication, 2017-2031
  • 11.3.1. Cancer
  • 11.3.2. Gastrointestinal Diseases / Disorders
  • 11.3.3. Congestive Heart Failure
  • 11.3.4. Rheumatoid Arthritis
  • 11.3.5. Hemophilia
  • 11.3.6. Immune Deficiencies
  • 11.3.7. Others
• 11.4. Market Value Forecast, by Therapy Type, 2017-2031
  • 11.4.1. Antibiotic/Antiviral
  • 11.4.2. Anti-coagulation
  • 11.4.3. Anti-emetics
  • 11.4.4. Blood Component Stimulating Factor
  • 11.4.5. Chemotherapy
  • 11.4.6. Nutrition
  • 11.4.7. Hydration
  • 11.4.8. Pain Management
• 11.5. Market Value Forecast, by End-user, 2017-2031
  • 11.5.1. Hospitals
  • 11.5.2. Ambulatory Surgical Centers
  • 11.5.3. Clinics
  • 11.5.4. Homecare Settings
• 11.6. Market Value Forecast, by Country, 2017-2031
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Product
  • 11.7.2. By Indication
  • 11.7.3. By Therapy Type
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe Infusion Therapy Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product, 2017-2031
  • 12.2.1. Infusion Pumps
    • 12.2.1.1. Ambulatory Infusion Pumps
    • 12.2.1.2. Stationary Infusion Pumps
    • 12.2.1.3. Syringe Infusion Pumps
    • 12.2.1.4. Disposable Pumps
    • 12.2.1.5. Large Volume Pumps
    • 12.2.1.6. Elastomeric Pumps
  • 12.2.2. Infusion Set
  • 12.2.3. Accessories
• 12.3. Market Value Forecast, by Indication, 2017-2031
  • 12.3.1. Cancer
  • 12.3.2. Gastrointestinal Diseases / Disorders
  • 12.3.3. Congestive Heart Failure
  • 12.3.4. Rheumatoid Arthritis
  • 12.3.5. Hemophilia
  • 12.3.6. Immune Deficiencies
  • 12.3.7. Others
• 12.4. Market Value Forecast, by Therapy Type, 2017-2031
  • 12.4.1. Antibiotic/Antiviral
  • 12.4.2. Anti-coagulation
  • 12.4.3. Anti-emetics
  • 12.4.4. Blood Component Stimulating Factor
  • 12.4.5. Chemotherapy
  • 12.4.6. Nutrition
  • 12.4.7. Hydration
  • 12.4.8. Pain Management
• 12.5. Market Value Forecast, by End-user, 2017-2031
  • 12.5.1. Hospitals
  • 12.5.2. Ambulatory Surgical Centers
  • 12.5.3. Clinics
  • 12.5.4. Homecare Settings
• 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.6.1. Germany
  • 12.6.2. U.K.
  • 12.6.3. France
  • 12.6.4. Italy
  • 12.6.5. Spain
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Product
  • 12.7.2. By Indication
  • 12.7.3. By Therapy Type
  • 12.7.4. By End-user
  • 12.7.5. By Country/Sub-region

13. Asia Pacific Infusion Therapy Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product, 2017-2031
  • 13.2.1. Infusion Pumps
    • 13.2.1.1. Ambulatory Infusion Pumps
    • 13.2.1.2. Stationary Infusion Pumps
    • 13.2.1.3. Syringe Infusion Pumps
    • 13.2.1.4. Disposable Pumps
    • 13.2.1.5. Large Volume Pumps
    • 13.2.1.6. Elastomeric Pumps
  • 13.2.2. Infusion Set
  • 13.2.3. Accessories
• 13.3. Market Value Forecast, by Indication, 2017-2031
  • 13.3.1. Cancer
  • 13.3.2. Gastrointestinal Diseases / Disorders
  • 13.3.3. Congestive Heart Failure
  • 13.3.4. Rheumatoid Arthritis
  • 13.3.5. Hemophilia
  • 13.3.6. Immune Deficiencies
  • 13.3.7. Others
• 13.4. Market Value Forecast, by Therapy Type, 2017-2031
  • 13.4.1. Antibiotic/Antiviral
  • 13.4.2. Anti-coagulation
  • 13.4.3. Anti-emetics
  • 13.4.4. Blood Component Stimulating Factor
  • 13.4.5. Chemotherapy
  • 13.4.6. Nutrition
  • 13.4.7. Hydration
  • 13.4.8. Pain Management
• 13.5. Market Value Forecast, by End-user, 2017-2031
  • 13.5.1. Hospitals
  • 13.5.2. Ambulatory Surgical Centers
  • 13.5.3. Clinics
  • 13.5.4. Homecare Settings
• 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 13.6.1. China
  • 13.6.2. Japan
  • 13.6.3. India
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Product
  • 13.7.2. By Indication
  • 13.7.3. By Therapy Type
  • 13.7.4. By End-user
  • 13.7.5. By Country/Sub-region

14. Latin America Infusion Therapy Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Product, 2017-2031
  • 14.2.1. Infusion Pumps
    • 14.2.1.1. Ambulatory Infusion Pumps
    • 14.2.1.2. Stationary Infusion Pumps
    • 14.2.1.3. Syringe Infusion Pumps
    • 14.2.1.4. Disposable Pumps
    • 14.2.1.5. Large Volume Pumps
    • 14.2.1.6. Elastomeric Pumps
  • 14.2.2. Infusion Set
  • 14.2.3. Accessories
• 14.3. Market Value Forecast, by Indication, 2017-2031
  • 14.3.1. Cancer
  • 14.3.2. Gastrointestinal Diseases / Disorders
  • 14.3.3. Congestive Heart Failure
  • 14.3.4. Rheumatoid Arthritis
  • 14.3.5. Hemophilia
  • 14.3.6. Immune Deficiencies
  • 14.3.7. Others
• 14.4. Market Value Forecast, by Therapy Type, 2017-2031
  • 14.4.1. Antibiotic/Antiviral
  • 14.4.2. Anti-coagulation
  • 14.4.3. Anti-emetics
  • 14.4.4. Blood Component Stimulating Factor
  • 14.4.5. Chemotherapy
  • 14.4.6. Nutrition
  • 14.4.7. Hydration
  • 14.4.8. Pain Management
• 14.5. Market Value Forecast, by End-user, 2017-2031
  • 14.5.1. Hospitals
  • 14.5.2. Ambulatory Surgical Centers
  • 14.5.3. Clinics
  • 14.5.4. Homecare Settings
• 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Product
  • 14.7.2. By Indication
  • 14.7.3. By Therapy Type
  • 14.7.4. By End-user
  • 14.7.5. By Country/Sub-region

15. Middle East & Africa Infusion Therapy Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast, by Product, 2017-2031
  • 15.2.1. Infusion Pumps
    • 15.2.1.1. Ambulatory Infusion Pumps
    • 15.2.1.2. Stationary Infusion Pumps
    • 15.2.1.3. Syringe Infusion Pumps
    • 15.2.1.4. Disposable Pumps
    • 15.2.1.5. Large Volume Pumps
    • 15.2.1.6. Elastomeric Pumps
  • 15.2.2. Infusion Set
  • 15.2.3. Accessories
• 15.3. Market Value Forecast, by Indication, 2017-2031
  • 15.3.1. Cancer
  • 15.3.2. Gastrointestinal Diseases / Disorders
  • 15.3.3. Congestive Heart Failure
  • 15.3.4. Rheumatoid Arthritis
  • 15.3.5. Hemophilia
  • 15.3.6. Immune Deficiencies
  • 15.3.7. Others
• 15.4. Market Value Forecast, by Therapy Type, 2017-2031
  • 15.4.1. Antibiotic/Antiviral
  • 15.4.2. Anti-coagulation
  • 15.4.3. Anti-emetics
  • 15.4.4. Blood Component Stimulating Factor
  • 15.4.5. Chemotherapy
  • 15.4.6. Nutrition
  • 15.4.7. Hydration
  • 15.4.8. Pain Management
• 15.5. Market Value Forecast, by End-user, 2017-2031
  • 15.5.1. Hospitals
  • 15.5.2. Ambulatory Surgical Centers
  • 15.5.3. Clinics
  • 15.5.4. Homecare Settings
• 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Product
  • 15.7.2. By Indication
  • 15.7.3. By Therapy Type
  • 15.7.4. By End-user
  • 15.7.5. By Country/Sub-region

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (by tier and size of companies)
• 16.2. Market Share Analysis, by Company, 2021
• 16.3. Company Profiles
  • 16.3.1. B. Braun Melsungen AG
    • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.1.2. Product Portfolio
    • 16.3.1.3. Financial Overview
    • 16.3.1.4. SWOT Analysis
    • 16.3.1.5. Strategic Overview
  • 16.3.2. Medtronic plc
    • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.2.2. Product Portfolio
    • 16.3.2.3. Financial Overview
    • 16.3.2.4. SWOT Analysis
    • 16.3.2.5. Strategic Overview
  • 16.3.3. Becton, Dickinson and Company
    • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.3.2. Product Portfolio
    • 16.3.3.3. Financial Overview
    • 16.3.3.4. SWOT Analysis
    • 16.3.3.5. Strategic Overview
  • 16.3.4. ICU medical (Smiths Medical)
    • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.4.2. Product Portfolio
    • 16.3.4.3. Financial Overview
    • 16.3.4.4. SWOT Analysis
    • 16.3.4.5. Strategic Overview
  • 16.3.5. Baxter International, Inc.
    • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.5.2. Product Portfolio
    • 16.3.5.3. Financial Overview
    • 16.3.5.4. SWOT Analysis
    • 16.3.5.5. Strategic Overview
  • 16.3.6. Polymedicure
    • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.6.2. Product Portfolio
    • 16.3.6.3. Financial Overview
    • 16.3.6.4. SWOT Analysis
    • 16.3.6.5. Strategic Overview
  • 16.3.7. BIO-MED
    • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.7.2. Product Portfolio
    • 16.3.7.3. Financial Overview
    • 16.3.7.4. SWOT Analysis
    • 16.3.7.5. Strategic Overview
  • 16.3.8. Terumo Medical Corporation
    • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.8.2. Product Portfolio
    • 16.3.8.3. Financial Overview
    • 16.3.8.4. SWOT Analysis
    • 16.3.8.5. Strategic Overview
  • 16.3.9. MEDIPRIM GmbH
    • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.9.2. Product Portfolio
    • 16.3.9.3. Financial Overview
    • 16.3.9.4. SWOT Analysis
    • 16.3.9.5. Strategic Overview
  • 16.3.10. Fresenius Kabi
    • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.10.2. Product Portfolio
    • 16.3.10.3. Financial Overview
    • 16.3.10.4. SWOT Analysis
    • 16.3.10.5. Strategic Overview
  • 16.3.11. Cardinal Health
    • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.11.2. Product Portfolio
    • 16.3.11.3. Financial Overview
    • 16.3.11.4. SWOT Analysis
    • 16.3.11.5. Strategic Overview

List of Tables

• Table 01: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 02: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017-2031
• Table 03: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017-2031
• Table 04: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
• Table 05: Global Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017-2031
• Table 06: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Region, 2017-2031 
• Table 07: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Country, 2017-2031
• Table 08: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 09: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017-2031
• Table 10: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017-2031
• Table 11: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
• Table 12: North America Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017-2031
• Table 13: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
• Table 14: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 15: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017-2031
• Table 16: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017-2031
• Table 17: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
• Table 18: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017-2031
• Table 19: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
• Table 20: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 21: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017-2031
• Table 22: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017-2031
• Table 23: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
• Table 24: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017-2031
• Table 25: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
• Table 26: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 27: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017-2031
• Table 28: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017-2031
• Table 29: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
• Table 30: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017-2031
• Table 31: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
• Table 32: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 33: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017-2031
• Table 34: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017-2031
• Table 35: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
• Table 36: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017-2031

List of Figures

• Figure 01: Global Infusion Therapy Market Value Share, by Product, 2021 and 2031
• Figure 02: Global Infusion Therapy Market Attractiveness Analysis, Product, 2022-2031
• Figure 03: Global Infusion Therapy Market (US$ Bn), by Infusion Pumps, 2017-2031
• Figure 04: Global Infusion Therapy Market (US$ Bn), by Infusion Set, 2017-2031
• Figure 05: Global Infusion Therapy Market (US$ Bn), by Accessories, 2017-2031
• Figure 06: Global Infusion Therapy Market, by Indication, 2021 and 2031
• Figure 07: Global Infusion Therapy Market Attractiveness Analysis, Indication, 2022-2031
• Figure 08: Global Infusion Therapy Market (US$ Bn), by Cancer, 2017-2031
• Figure 09: Global Infusion Therapy Market (US$ Bn), by Gastrointestinal Diseases/Disorders, 2017-2031
• Figure 10: Global Infusion Therapy Market (US$ Bn), by Congestive Heart Failure, 2017-2031
• Figure 11: Global Infusion Therapy Market (US$ Bn), by Rheumatoid Arthritis, 2017-2031
• Figure 12: Global Infusion Therapy Market (US$ Bn), by Hemophilia, 2017-2031
• Figure 13: Global Infusion Therapy Market (US$ Bn), by Immune Deficiencies, 2017-2031
• Figure 14: Global Infusion Therapy Market (US$ Bn), by Others, 2017-2031
• Figure 15: Global Infusion Therapy Market, by Therapy, 2021 and 2031
• Figure 16: Global Infusion Therapy Market Attractiveness Analysis, Therapy, 2022-2031
• Figure 17: Global Infusion Therapy Market (US$ Bn), by Antibiotic/Antiviral, 2017-2031
• Figure 18: Global Infusion Therapy Market (US$ Bn), by Anti-coagulation, 2017-2031
• Figure 19: Global Infusion Therapy Market (US$ Bn), by Anti-emetics, 2017-2031
• Figure 20: Global Infusion Therapy Market (US$ Bn), by Blood Component Stimulating Factor, 2017-2031
• Figure 21: Global Infusion Therapy Market (US$ Bn), by Chemotherapy, 2017-2031
• Figure 22: Global Infusion Therapy Market (US$ Bn), by Nutrition, 2017-2031
• Figure 23: Global Infusion Therapy Market (US$ Bn), by Hydration, 2017-2031
• Figure 24: Global Infusion Therapy Market (US$ Bn), by Pain Management, 2017-2031
• Figure 25: Global Infusion Therapy Market, by End-user, 2021 and 2031
• Figure 26: Global Infusion Therapy Market Attractiveness Analysis, End-user, 2022-2031
• Figure 27: Global Infusion Therapy Market (US$ Bn), by Hospitals, 2017-2031
• Figure 28: Global Infusion Therapy Market (US$ Bn), by Ambulatory Surgical Centers, 2017-2031
• Figure 29: Global Infusion Therapy Market (US$ Bn), by Clinics, 2017-2031
• Figure 30: Global Infusion Therapy Market (US$ Bn), by Homecare Settings, 2017-2031
• Figure 31: Global Infusion Therapy Market Value Share Analysis, by Region, 2021 and 2031
• Figure 32: Global Infusion Therapy Market Attractiveness Analysis, by Region, 2022-2031
• Figure 33: North America Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 34: North America Infusion Therapy Market Value Share Analysis, by Country, 2021 and 2031
• Figure 35: North America Infusion Therapy Market Attractiveness Analysis, by Country, 2022-2031
• Figure 36: North America Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
• Figure 37: North America Infusion Therapy Market Attractiveness Analysis, by Product, 2022-2031
• Figure 38: North America Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
• Figure 39: North America Infusion Therapy Market Attractiveness Analysis, by Indication, 2022-2031
• Figure 40: North America Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
• Figure 41: North America Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022-2031
• Figure 42: North America Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 43: North America Infusion Therapy Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 44: Europe Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 45: Europe Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
• Figure 46: Europe Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 47: Europe Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
• Figure 48: Europe Infusion Therapy Market Attractiveness Analysis, by Product, 2022-2031
• Figure 49: Europe Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
• Figure 50: Europe Infusion Therapy Market Attractiveness Analysis, by Indication, 2022-2031
• Figure 51: Europe Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
• Figure 52: Europe Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022-2031
• Figure 53: Europe Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 54: Europe Infusion Therapy Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 55: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 56: Asia Pacific Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
• Figure 57: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 58: Asia Pacific Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
• Figure 59: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Product, 2022-2031
• Figure 60: Asia Pacific Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
• Figure 61: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Indication, 2022-2031
• Figure 62: Asia Pacific Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
• Figure 63: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022-2031
• Figure 64: Asia Pacific Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 65: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 66: Latin America Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 67: Latin America Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
• Figure 68: Latin America Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 69: Latin America Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
• Figure 70: Latin America Infusion Therapy Market Attractiveness Analysis, by Product, 2022-2031
• Figure 71: Latin America Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
• Figure 72: Latin America Infusion Therapy Market Attractiveness Analysis, by Indication, 2022-2031
• Figure 73: Latin America Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
• Figure 74: Latin America Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022-2031
• Figure 75: Latin America Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 76: Latin America Infusion Therapy Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 77: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 78: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
• Figure 79: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 80: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
• Figure 81: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Product, 2022-2031
• Figure 82: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
• Figure 83: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Indication, 2022-2031
• Figure 84: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
• Figure 85: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022-2031
• Figure 86: Middle East & Africa Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 87: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by End-user, 2022-2031